Adler CH, Beach TG (2010) Variability of diffuse plaques and amyloid angiopathy in Parkinson’s disease with mild cognitive impairment (Correspondence). Acta Neuropathol 120:831–832

Article  Google Scholar 

Adler CH, Caviness JN, Sabbagh MN, Shill HA, Connor DJ, Sue L, Evidente VG, Driver-Dunckley E, Beach TG (2010) Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment. Acta Neuropathol 120:827–828

Article  PubMed  PubMed Central  Google Scholar 

Aldaz T, Nigro P, Sánchez-Gómez A, Painous C, Planellas L, Santacruz P, Cámara A, Compta Y, Valldeoriola F, Martí MJ, Muñoz E (2019) Non-motor symptoms in Huntington’s disease: a comparative study with Parkinson’s disease. J Neurol 266:1340–1350

Article  PubMed  Google Scholar 

Alqahtani T, Deore SL, Kide AA, Shende BA, Sharma R, Dadarao Chakole R, Nemade LS, Kishor Kale N, Borah S, Shrikant Deokar S, Behera A, Dhawal Bhandari D, Gaikwad N, Kalam Azad A, Ghosh A (2023) Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease, and Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis -an updated review. Mitochondrion 71:83–92

Article  CAS  PubMed  Google Scholar 

Andrews SC, Langbehn DR, Craufurd D, Durr A, Leavitt BR, Roos RA, Tabrizi SJ, Stout JC (2021) Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington’s disease. Psychol Med 51:1338–1344

Article  CAS  PubMed  Google Scholar 

Aracil-Bolaños I, Martínez-Horta S, González-de-Echávarri JM, Sampedro F, Pérez-Pérez J, Horta-Barba A, Campolongo A, Izquierdo C, Gómez-Ansón B, Pagonabarraga J, Kulisevsky J (2022) Structure and dynamics of large-scale cognitive networks in Huntington’s disease. Mov Disord 37:343–353

Article  PubMed  Google Scholar 

Baake V, Reijntjes R, Dumas EM, Thompson JC, Roos RAC (2017) Cognitive decline in Huntington’s disease expansion gene carriers. Cortex 95:51–62

Article  PubMed  Google Scholar 

Barry J, Bui MTN, Levine MS, Cepeda C (2022) Synaptic pathology in Huntington’s disease: beyond the corticostriatal pathway. Neurobiol Dis 162:105574

Article  CAS  PubMed  Google Scholar 

Bessi V, Mazzeo S, Bagnoli S, Giacomucci G, Ingannato A, Ferrari C, Padiglioni S, Franchi V, Sorbi S, Nacmias B (2021) The effect of CAG repeats within the non-pathological range in the HTT gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment. Diagnostics (Basel) 11:1051

Article  CAS  PubMed  Google Scholar 

Bunner KD, Rebec GV (2016) Corticostriatal dysfunction in Huntington’s disease: the basics. Front Hum Neurosci 10:317

Article  PubMed  PubMed Central  Google Scholar 

Callahan JW, Abercrombie ED (2011) In vivo dopamine efflux is decreased in striatum of both fragment (R6/2) and full-length (YAC128) transgenic mouse models of Huntington’s disease. Front Syst Neurosci 5:61

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cavallo M, Sergi A, Pagani M (2022) Cognitive and social cognition deficits in Huntington’s disease differ between the prodromal and the manifest stages of the condition: a scoping review of recent evidence. Br J Clin Psychol 61:214–241

Article  PubMed  Google Scholar 

Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH (2007) Defining mild cognitive impairment in Parkinson’s disease. Mov Disord 22:1272–1277

Article  PubMed  Google Scholar 

Cepeda C, Hurst RS, Calvert CR, Hernández-Echeagaray E, Nguyen OK, Jocoy E, Christian LJ, Ariano MA, Levine MS (2003) Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington’s disease. J Neurosci 23:961–969

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chaganti SS, McCusker EA, Loy CT (2017) What do we know about late onset Huntington’s disease? J Huntingtons Dis 6:95–103

Article  PubMed  PubMed Central  Google Scholar 

Chan ST, Mercaldo ND, Ravina B, Hersch SM, Rosas HD (2021) Association of dilated perivascular spaces and disease severity in patients with Huntington disease. Neurology 96:e890–e894

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, Squitieri F (2006) Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington’s disease. J Nucl Med 47:215–222

CAS  PubMed  Google Scholar 

Coppen EM, Grond JV, Hafkemeijer A, Barkey Wolf JJH, Roos RAC (2018a) Structural and functional changes of the visual cortex in early Huntington’s disease. Hum Brain Mapp 39:4776–4786

Article  PubMed  PubMed Central  Google Scholar 

Coppen EM, van der Grond J, Hart EP, Lakke E, Roos RAC (2018b) The visual cortex and visual cognition in Huntington’s disease: an overview of current literature. Behav Brain Res 351:63–74

Article  PubMed  Google Scholar 

Corey-Bloom J, Williams ME, Beltran-Najera I, Mustafa AI, Snell CM, Castleton J, Smith H, Wright B, Gilbert PE (2020) Central cognitive processing speed is an early marker of Huntington’s disease onset. Mov Disord Clin Pract 8:100–105

Article  PubMed  PubMed Central  Google Scholar 

Cummings DM, Milnerwood AJ, Dallérac GM, Vatsavayai SC, Hirst MC, Murphy KP (2007) Abnormal cortical synaptic plasticity in a mouse model of Huntington’s disease. Brain Res Bull 72:103–107

Article  CAS  PubMed  Google Scholar 

Davis MY, Keene CD, Jayadev S, Bird T (2014) The co-occurrence of Alzheimer’s disease and Huntington’s disease: a neuropathological study of 15 elderly Huntington’s disease subjects. J Huntingtons Dis 3:209–217

Article  CAS  PubMed  Google Scholar 

DiProspero NA, Chen EY, Charles V, Plomann M, Kordower JH, Tagle DA (2004) Early changes in Huntington’s disease patient brains involve alterations in cytoskeletal and synaptic elements. J Neurocytol 33:517–533

Article  PubMed  Google Scholar 

Domínguez DJ, Poudel G, Stout JC, Gray M, Chua P, Borowsky B, Egan GF, Georgiou-Karistianis N (2017) Longitudinal changes in the fronto-striatal network are associated with executive dysfunction and behavioral dysregulation in Huntington’s disease: 30 months IMAGE-HD data. Cortex 92:139–149

Article  Google Scholar 

Duff K, Paulsen J, Mills J, Beglinger LJ, Moser DJ, Smith MM, Langbehn D, Stout J, Queller S, Harrington DL (2010) Mild cognitive impairment in prediagnosed Huntington disease. Neurology 75:500–507

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dumas EM, Say MJ, Jones R, Labuschagne I, O’Regan AM, Hart EP, van den Bogaard SJ, Queller S, Justo D, Coleman A, Dar Santos RC, Dürr A, Leavitt BR, Tabrizi SJ, Roos RA, Stout JC (2012a) Visual working memory impairment in premanifest gene-carriers and early Huntington’s disease. J Huntingtons Dis 1:97–106

Article  PubMed  Google Scholar 

Dumas EM, van den Bogaard SJ, Ruber ME, Reilman RR, Stout JC, Craufurd D, Hicks SL, Kennard C, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA (2012b) Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington’s disease. Hum Brain Mapp 33:203–212

Article  PubMed  Google Scholar 

Dumas EM, van den Bogaard SJ, Middelkoop HA, Roos RA (2013) A review of cognition in Huntington’s disease. Front Biosci (Schol Ed) 5:1–18

Article  PubMed  Google Scholar 

Duyckaerts C, Joyon N, Dürr A (2014) Neurodegenerative diseases linked to trinucleotide repeats. In: Kovacs G (ed) Neuropathology of Neurodegenerative diseases: a practical guide. Cambridge University Press Cambridge, pp 195–208

Chapter  Google Scholar 

Espina M, Di Franco N, Brañas-Navarro M, Navarro IR, Brito V, Lopez-Molina L, Costas-Insua C, Guzmán M, Ginés S (2023) The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington’s disease R6/1 mice. Neurobiol Dis 184:106225

Article  CAS  PubMed  Google Scholar 

Fernández-Nogales M, Cabrera JR, Santos-Galindo M, Hoozemans JJ, Ferrer I, Rozemuller AJ, Hernández F, Avila J, Lucas JJ (2014) Huntington’s disease is a four-repeat tauopathy with tau nuclear rods. Nat Med 20:881–885

Article  PubMed  Google Scholar 

Fink KD, Rossignol J, Crane AT, Davis KK, Bavar AM, Dekorver NW, Lowrance SA, Reilly MP, Sandstrom MI, von Hörsten S, Lescaudron L, Dunbar GL (2012) Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington’s disease. Behav Neurosci 126:479–487

Article  PubMed  Google Scholar 

Fricker M, Tolkovsky AM, Borutaite V, Coleman M, Brown GC (2018) Neuronal cell death. Physiol Rev 98:813–880

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gabery S, Kwa JE, Cheong RY, Baldo B, Ferrari Bardile C, Tan B, McLean C, Georgiou-Karistianis N, Poudel GR, Halliday G, Pouladi MA, Petersén Å (2021) Early white matter pathology in the fornix of the limbic system in Huntington disease. Acta Neuropathol 142:791–806

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giralt A, Saavedra A, Alberch J, Pérez-Navarro E (2012) Cognitive dysfunction in Huntington’s disease: humans, mouse models and molecular mechanisms. J Huntingtons Dis 1:155–173

Article  PubMed  Google Scholar 

Glidden AM, Luebbe EA, Elson MJ, Goldenthal SB, Snyder CW, Zizzi CE, Dorsey ER, Heatwole CR (2020) Patient-reported impact of symptoms in Huntington disease: PRISM-HD. Neurology 94:e2045–e2053

Article  PubMed  Google Scholar